Cite
HARVARD Citation
Loglio, A. et al. (n.d.). Baseline clinical features but not TLL1 variants predicts HCC onset in Caucasian compensated HBV cirrhotics treated by Entecavir or Tenofovir for 8 years. Digestive and liver disease. 50 (1), pp. 51-. [Online].